NMRA — Neumora Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
U.S. STOCKS ON THE MOVE-Datadog, Terawulf
U.S. STOCKS ON THE MOVE-Crypto Stocks, Travel Stocks, Micron
Neumora plummets after scrapping depression drug development
Neumora scraps depression drug development after repeated trial failures (updated)
Neumora Therapeutics scraps depression drug after two late-stage trial failures
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. RESEARCH ROUNDUP- American Express Co, Ameriprise Financial, Mastercard
U.S. STOCKS ON THE MOVE-Synchrony Financial, Coinbase, Versant Media Group
U.S. STOCKS ON THE MOVE-Qualcomm, Costco, Topgolf Callaway Brands
U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive
U.S. STOCKS ON THE MOVE-Arista Networks, Silver Miners, IBM
Neumora rises as Alzheimer’s drug shows promise in easing agitation
Brief: Neumora Therapeutics Announces Initiation Of Phase 1 Clinical Study Of M4 Positive Allosteric Modulator NMRA-898
Brief: Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated With NMRA-215 In Preclinical Diet-Induced Obesity Model
U.S. STOCKS ON THE MOVE-Hershey, Eli Lilly, energy stocks